XORTX Therapeutics Inc. (XRTX)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

3 annual periodsNewest to oldest
202120202019
Research & development$853,124$277,455$39,897
Net income−$1.7M−$1.3M−$629,576

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.